CancerNetwork® sat down with Jeffrey Graham, MD, FRCPC, to discuss the effectiveness of immune checkpoint inhibitors as frontline therapy for non–clear cell renal cell carcinoma
Jeffrey Graham, MD, FRCPC
Advertisement
Articles by Jeffrey Graham, MD, FRCPC
Advertisement
Latest Updated Articles
Jeffrey Graham, MD, Talks Immunotherapy Use in Frontline Non-Clear Cell RCCPublished: March 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Zanzalintinib Combo Improves Survival in Pretreated Metastatic CRC
3
Temab-A Displays Early Efficacy in Locally Advanced/Metastatic PDAC
4
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
5
